TFP
GILD icon

Tilia Fiduciary Partners’s Gilead Sciences GILD Stock Holding History

Tilia Fiduciary Partners’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.69M Buy
21,278
+769
+4% +$101K 1.27% 25
2026
Q1 		$2.86M Buy
+20,509
New +$2.87M 1.57% 18

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Tilia Fiduciary Partners's GILD Position: Q2 2026 in Review

Tilia Fiduciary Partners increased its Gilead Sciences (GILD) stake by 3.7% in Q2 2026, buying an estimated $101K and bringing the position to 21,278 shares worth $2.69M. The position accounts for 1.27% of the portfolio, ranked #25.

Tilia Fiduciary Partners first reported a position in GILD in Q1 2026 and has held it in 2 quarters since. The position peaked at $2.86M in Q1 2026. 2,268 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Tilia Fiduciary Partners held 21,278 shares of Gilead Sciences worth $2.69M as of Q2 2026.
  • Tilia Fiduciary Partners bought 769 Gilead Sciences shares in Q2 2026, an estimated $101K.
  • Gilead Sciences made up 1.27% of Tilia Fiduciary Partners's portfolio in Q2 2026, its #25 holding.
  • Tilia Fiduciary Partners first reported a position in Gilead Sciences in Q1 2026 and has held it in 2 quarters since.
  • Tilia Fiduciary Partners's Gilead Sciences position peaked at $2.86M in Q1 2026.
  • 2,268 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Tilia Fiduciary Partners's 13F filing for Q2 2026, filed 18 Aug 2026.